Company Overview and News

 
IGM Financial: Is Its 6.3%-Yielding Dividend Safe?

2018-09-27 seekingalpha
The company continues to face strong secular headwinds due to competitions from low cost passive products, as well as bank offerings.
IGM IGIFF

 
CI Financial: Net Outflows Continue

2018-08-22 seekingalpha
The company continues to face strong headwinds from low cost ETFs as well as mutual funds offered by other larger Canadian banks.
IGM CIX IGIFF CIFAF

 
IGM Financial Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-03 seekingalpha
The following slide deck was published by IGM Financial Inc. in conjunction with their 2018 Q2 earnings call.
IGM IGIFF

4
CANADA STOCKS - TSX rises 0.20 percent

2018-08-02 reuters
Aug 2 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 32.39 points, or 0.20 percent, to 16,409.16. * Leading the index were Gildan Activewear Inc, up 21.6 percent, Norbord Inc, up 9 percent, and Seven Generations Energy Ltd , higher by 8.1 percent. * Lagging shares were Kinross Gold Corp, down 4.1 percent, IGM Financial Inc, down 3.9 percent, and Torex Gold Resources Inc, lower by 3.8 percent.
GIL ACBFF IGM K NBRXF TXG OSB ACB KGC BDRPF SVRGF IGIFF GIL VII TORXF

16
TSX heads down in broad-based retreat across most market sectors

2018-08-02 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
IGM IGIFF TSG CWEGF CR

 
AGF Management: Is Its Improved Net Sales Sustainable?

2018-07-30 seekingalpha
AGF Management continues to face strong headwinds from low cost ETFs as well as mutual funds offered by other larger Canadian banks.
IGM AGFMF IGIFF

 
IGM Financial: Is Its Headwinds Manageable?

2018-07-23 seekingalpha
IGM Financial is facing strong headwinds from low-cost ETFs as well as mutual funds offered by other Canadian banks.
IGM IGIFF

 
Taking the helm from famous founder, Jay Shah gets Personal Capital out of Vanguard's shadow with new shape, new deals and a 70% leap in assets | RIABiz

2018-07-10 riabiz
Taking the helm from famous founder, Jay Shah gets Personal Capital out of Vanguard's shadow with new shape, new deals and a 70% leap in assets
IGM IGIFF

12
An Undervalued Large-Cap Financial Firm You Probably Have Never Heard Of

2018-05-18 seekingalpha
Canadian financial firm Power Corporation of Canada is a holding company with interesting and diverse assets.
BNPQY IGM BNPQF BNPZY GWLOF GWO PWF IGIFF GWLIF GRWTF POFNF

2
Power Corp. prepares to exit newspaper business, targets U.S. expansion

2018-05-11 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
IGM PWF IGIFF POFNF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to TSX:IGM / Igm Financial Inc. on message board site Silicon Investor.

ARADIGM CORP. ARDM ARADIGM CORP. ARDM ARADIGM CORP. ARDM Aradigm (ARDM) Aradigm (ARDM) Aradigm (ARDM)
CIDM - Cinedigm Digital Cinema Corp. CIDM - Cinedigm Digital Cinema Corp. CIDM - Cinedigm Digital Cinema Corp. GIGM - Asian Internet Gaming GIGM - Asian Internet Gaming GIGM - Asian Internet Gaming
Sigma Designs- Up 50% per Month- Why? Sigma Designs- Up 50% per Month- Why? Sigma Designs- Up 50% per Month- Why? PDGT - Paradigm Tactical Products Inc. (Bulls Board) PDGT - Paradigm Tactical Products Inc. (Bulls Board) PDGT - Paradigm Tactical Products Inc. (Bulls Board)
The 2004 Bigmouth Election Challenge The 2004 Bigmouth Election Challenge The 2004 Bigmouth Election Challenge SigmaTel - SGTL SigmaTel - SGTL SigmaTel - SGTL
Paradigm Genetics -- PDGM Paradigm Genetics -- PDGM Paradigm Genetics -- PDGM Paradigms Paradigms Paradigms